Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/7138
DC FieldValueLanguage
dc.contributor.authorCamargo, Cristina Piresen_US
dc.contributor.authorSaliba, Maritaen_US
dc.contributor.authorSaad, Elio Assaaden_US
dc.contributor.authorMilan, Milanieen_US
dc.contributor.authorCaldera, José Mauricioen_US
dc.date.accessioned2023-12-20T09:10:38Z-
dc.date.available2023-12-20T09:10:38Z-
dc.date.issued2023-
dc.identifier.issn01028650-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/7138-
dc.description.abstractPalpebral congenital melanocytic nevi (PCMN) is a rare congenital skin lesion affecting the eyelids that can lead to cosmetic and psychological concerns and potential health risks such as malignancy. Several authors have analyzed therapeutical strategies to treat PCMN. However, there was no consensus in the literature. This systematic review aimed to evaluate the effectiveness, safety, and success of treatments of PCMN.en_US
dc.language.isoengen_US
dc.publisherNational Library of Medicineen_US
dc.subjectEyelid Neoplasmsen_US
dc.subjectNevusen_US
dc.subjectPigmenteden_US
dc.titleTreatments of palpebral congenital melanocytic nevus: a systematic reviewen_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1590/acb384823-
dc.identifier.pmid38055392-
dc.identifier.scopus2-s2.0-85178475018-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85178475018-
dc.contributor.affiliationFaculty of Medicineen_US
dc.contributor.affiliationFaculty of Medicineen_US
dc.contributor.affiliationFaculty of Medicineen_US
dc.description.volume38en_US
dc.date.catalogued2023-12-20-
dc.description.statusPublisheden_US
dc.identifier.openURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691178/en_US
dc.relation.ispartoftextActa Cirurgica Brasileiraen_US
Appears in Collections:Faculty of Medicine
Show simple item record

Record view(s)

28
checked on Sep 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.